Metabolic Disorders: Clinical Trials

7 trials for Metabolic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 terminated. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 3, Recruiting 2, Terminated 2
Phase 22Recruiting 2

Follow Metabolic Disorders: new trials by email Literature Review of Metabolic Disorders trials Research Report on Metabolic Disorders

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of NAE on Polycystic Ovarian Syndrome (PCOS)
Herbal Formulation, Metformin XR, Metformin 750 mg and herbal formulation 500 mg - Polycystic Ovarian Syndrome (PCOS), Infertility
Phase 1CompletedJinnah Sindh Medical University1162025-04-102026-06-22
A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects
AZD2693, Placebo - Metabolic Disorders, Non-alcoholic Steatohepatitis
Phase 1CompletedAstraZeneca732019-10-282021-11-26
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
RIC regimen, GVHD prophylaxis regimen - Severe Sickle Cell Disease, Bone Marrow Failure Syndromes
Phase 1 / Phase 2RecruitingWashington University School of Medicine292017-03-202026-05-29
A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders
ProHema-CB Transplant - Metabolic Disorders
Phase 1TerminatedFate Therapeutics12015-06-012018-10-10
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
BPX-501 and Rimiducid - Primary Immune Deficiency Disorders, Hemophagocytic Lymphohistiocytosis
Phase 1TerminatedBellicum Pharmaceuticals12015-02-012024-03-25
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
REGN1500, placebo - Metabolic Disorders
Phase 1CompletedRegeneron Pharmaceuticals552014-04-012015-09-30
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Treatment Plan 1: Stratum 1, Treatment Plan 2: Strata 2, 3, or 4, GVHD Regimen A: UCB Recipients - Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders
Phase 1 / Phase 2RecruitingWashington University School of Medicine2202001-12-012026-09-16

Narrower conditions

Metabolic Diseases (7)  ·  Hemoglobinopathies (3)  ·  Anemia, Sickle Cell (2)  ·  Anemia, Diamond-Blackfan (1)  ·  Bone Marrow Failure Disorders (1)  ·  Congenital Bone Marrow Failure Syndromes (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dyskeratosis Congenita (1)  ·  Dyslipidemias (1)  ·  Fanconi Anemia (1)  ·  Granulomatous Disease, Chronic (1)  ·  Immune System Diseases (1)  ·  Infertility (1)  ·  Insulin Resistance (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)

Broader conditions

Nutritional and Metabolic Diseases (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Bone Marrow Diseases (2)  ·  Digestive System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Lipid Metabolism Disorders (2)  ·  Adnexal Diseases (1)  ·  Anemia, Aplastic (1)

Interventions

Metformin (1)  ·  evinacumab (1)

Sponsors

Washington University School of Medicine (2)  ·  AstraZeneca (1)  ·  Bellicum Pharmaceuticals (1)  ·  Fate Therapeutics (1)  ·  Jinnah Sindh Medical University (1)  ·  Regeneron Pharmaceuticals (1)

Countries

United States (6)  ·  Canada (1)  ·  Pakistan (1)

Top investigators

Shalini Shenoy, MD (2)  ·  Chris Storgard, MD (1)  ·  David Han, MD (1)

Results publications

PMID 15592491, PMID 16990602, PMID 18026148, PMID 18500373, PMID 26348869, PMID 31242752, PMID 32813873, PMID 39798707